目的:探讨盐敏感性高血压患者胰岛素抵抗与脂联素代谢异常的关系。方法:对100例高血压患者采用急性盐水负荷试验,确定65例为盐敏感性(SS)高血压患者,35例为盐不敏感性(NSS)高血压患者,选定正常人50例为对照组,分别测其胰岛素水平、血脂、血尿酸及脂联素水平。结果:高血压患者存尿酸、胆固醇、甘油三酯水平升高(Plt;0.01),SS组较NSS组的血尿酸、血胆固醇、血甘油三脂增高(Plt;0.01)。SS组脂联素［(6.04±2.08)ng/mL］,较NSS组［(7.89±3.35)ng/mL(Plt;0.01)］降低,且SS组存在胰岛素抵抗,HOMA指数分别为［2.54±0.53,2.21±0.55(Plt;0.01)］。血浆脂联素水平与胰岛素抵抗指标存在正相关,r=-0.36,(Plt;0.01)。结论:盐敏感性高血压患者存在胰岛素抵抗及脂联素降低,胰岛素抵抗可能是其他代谢异常及脂联素降低的基础。
ObjectiveTo analyze the clinical characteristics of thrombo embolism (TE) in Chinese hypertrophic cardiomyopathy (HCM) patients. MethodsThis study retrospectively analyzed HCM patients admitted to West China Hospital of Sichuan University. The endpoints were defined as a composite of TE events, including ischemic stroke, transient ischemic attack, and peripheral arterial embolization. ResultsA total of 537 HCM patients were included with a median follow-up of 4.2 years. Forty-two patients reached the TE endpoint and the incidence was 1.9%. The annual incidence of TE was approximately 1.1% and 6.6% for HCM patients without/with atrial fibrillation, respectively. The recurrence rate of TE was high (approximately 26.2%). The mean age was 66.4±13.7 years for the first TE, and the incidence of TE was significantly increased at age ≥70 years. ConclusionThe incidence of TE is high in HCM patients, especially in those with atrial fibrillation, and the recurrence rate of TE is also high.
目的 阻塞性睡眠呼吸暂停低通气综合征（OSAHS）可引起心血管疾病发生增高，是高血压病及冠心病等的独立危险因素。打鼾是OSAHs的主要临床症状。本研究的主要目的是了解成都地区自然人群打鼾发生情况及其与心血管疾病危险因素的关系。 方法 2007年在成都市成华区采用随机抽样方法对男、女性共711人进行了心血管疾病危险因素调查[年龄45～80岁，平均（3.28 ± 6.25）岁，男性患者占所有患者的57.8%]，主要包括问卷调查、体格检查及血液学检查等，其中打鼾调查主要包括打鼾时间、次数及憋醒情况。将与打鼾相关的3个指标综合考虑后，计算出打鼾的严重程度，并分析了其与心血管疾病危险因素的关系。 结果 男性人群中打鼾率较女性高（62.0%、51.0%，P=0.003），且重度及极重度打鼾率也较女性高。随着打鼾的严重程度增加，体质量指数、血肌酐及尿酸等心血管疾病危险因素逐渐升高（趋势P均＜0.05），而高密度脂蛋白胆固醇逐渐降低（P=0.001）。另外，随着打鼾的严重程度增加，高血压患病率及收缩压也逐渐升高，但无统计学意义（趋势P=0.063，0.08）。 结论 成都地区中老年城镇人群的打鼾率较高，且男性高于女性。另外，随着打鼾的严重程度增加，心血管疾病危险因素也逐渐升高。这提示我们在临床工作中，对于打鼾的患者需要加强心血管疾病危险因素的筛查及干预，以期减少它的发生发展。
ObjectiveTo investigate the correlation between lipid accumulation product (LAP) and risk of ischemic cardiovascular disease (ICVD). MethodsThis cross-sectional study was performed among community residents from an urban community in Chengdu area between September 2011 and June 2012. Questionnaire survey was carried out. Each individual underwent biochemistry analysis and physical examination. In addition, brachial-ankle pulse wave velocity (BaPWV) and augmentation index (AI) were detected. Pearson correlation analysis was performed to explore the relationship between LAP and each cardiovascular risk factor. Liner regression model was used to analyze the relationship between LAP and ICVD. ResultsA total of 780 individuals with complete data were included in the analysis. LAP was correlated with blood pressure, total cholesterol, high density lipoprotein cholesterol, fasting blood glucose, and BaPWV (P＜0.05). LAP was associated with the risk of ICVD (r=0.253, P＜0.001). After being adjusted with sex, age and other cardiovascular risk factors, LAP was also correlated with the risk of ICVD (r=0.050, P＜0.001). ConclusionsHigh LAP is associated with elevated cardiovascular risks and subclinical vascular damage. In addition, LAP is correlated with ICVD risk, thus it may be used to predict the incidence of ICVD to some extent. However, as the correlation is weak, our study does not support the direct use of this indicator to predict ICVD. Large-sample studies based on different races and ages are needed.